ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s

Someone in the world develops dementia every three seconds. Alzheimer’s disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to 131.5M by 2050, that is, unless companies like ProMis Neurosciences (PMN.T) can do the unthinkable. See, our understanding of Alzheimer’s has […]

Equity.Guru Podcast: Titan Pharmaceuticals (TTNP.NASDAQ)

Titan Pharmaceuticals (TTNP.Q) is an American pharmaceutical company based out of San Francisco, California. The company has recently relaunched Probuphine, its six-month treatment for Opioid Use Disorder (OUD). The company reacquired the rights to Probuphine from Braeburn Pharmaceuticals. Since the June 2018 relaunch, sales of Probuphine have increased over 20% and […]